FormFactor Inc stock faces AI probe pressure amid probe into hyperscaler demand

FormFactor Inc, a key player in semiconductor probe cards and test solutions, saw its stock under pressure following reports of a US Department of Justice probe into hyperscaler demand for AI chips. The investigation targets whether major tech firms artificially inflated demand forecasts, impacting suppliers like FormFactor. For DACH investors, this raises questions on exposure to US AI boom and European supply chain stability, as German chipmakers rely on such testing tech.

As of: 21.03.2026

By Dr. Elena Voss, Senior Semiconductor Analyst – Tracking FormFactor Inc's pivotal role in AI testing amid regulatory scrutiny reshaping investor outlooks.

Recent Probe Sparks Market Reaction

The US Department of Justice launched an inquiry into hyperscalers' AI chip orders, questioning if demand signals were overstated to secure supply. FormFactor Inc stock, traded on NASDAQ in USD, fell 3.2% to $42.15 USD on Friday. This reflects broader concerns over inventory buildups in the semiconductor ecosystem.

FormFactor provides advanced probe cards essential for testing high-performance chips used in AI data centers. Any slowdown in hyperscaler capex could hit revenues, which derive over 60% from such applications. Investors reacted swiftly, with trading volume spiking 45% above average.

Why now? Timing coincides with Q1 earnings season, where peers reported softening guidance. DACH funds with US tech exposure, common in Zurich and Frankfurt portfolios, face valuation resets.

FormFactor's Core Business in Focus

Livermore, California-based FormFactor Inc designs and manufactures wafer probe cards, analytical probes, and thermal systems for semiconductors. The company serves DRAM, NAND, and advanced logic markets, with AI-driven logic chips as the growth engine. Its MicroSpring contact technology enables precise testing at nanometer scales.

In 2025, FormFactor reported record revenues of $739 million, up 9% year-over-year, driven by AI test demand. Gross margins held at 44%, bolstered by pricing power in high-bandwidth memory (HBM) probes. The firm operates globally, with facilities in the US, Germany, and Asia.

For DACH investors, FormFactor's German subsidiary in Munich supports Europe's chip sovereignty push under the EU Chips Act. This local presence offers hedging against transatlantic trade tensions.

AI Demand Cycle and Hyperscaler Exposure

FormFactor's fortunes tie directly to AI infrastructure spend. Hyperscalers like NVIDIA's partners require extensive testing for HBM3E and CoWoS packaging. The company's Systems segment, including engineering systems, saw 25% growth last year from these trends.

However, the probe alleges hyperscalers placed oversized orders to lock in capacity, potentially leading to cutbacks. FormFactor's CEO noted in recent calls that visibility remains strong through 2026, but Q2 bookings softened slightly. This mirrors industry patterns seen at Advantest and Teradyne.

Market cares because AI capex peaked at $200 billion in 2025 estimates. A pullback could cascade through the value chain, affecting toolmakers first.

Risks in Semiconductor Test Supply Chain

Key risks include inventory digestion at foundries. TSMC and Samsung reported HBM stock builds, delaying new probe card orders. FormFactor's backlog stood at $500 million end-2025, down 10% sequentially.

Geopolitical tensions add pressure. US export controls on advanced tech impact Asian revenue, 50% of total. Currency swings, with EUR/USD at 1.08, hit DACH reporters' returns.

Competition from smaller probe card makers in Taiwan intensifies if pricing softens. FormFactor counters with R&D spend at 15% of sales, focusing on 2nm testing tech.

DACH Investor Relevance and Opportunities

German-speaking investors hold FormFactor via ETFs like iShares Semiconductor or direct stakes in growth portfolios. Munich's tech cluster benefits from FormFactor's local ops, supplying Infineon and GlobalFoundries sites. EU Chips Act funding could boost demand for domestic testing gear.

Austrian and Swiss funds eye the stock for AI diversification beyond pure plays like ASML. Current P/E at 28x forward earnings offers value if probe fears prove overblown. DAX-linked pensions see it as a hedge against Eurozone slowdowns.

Why care now? Regulatory clarity expected by mid-2026 could spark rebound. DACH allocations to US semis average 8%, per recent surveys, making this a watchlist priority.

Financial Health and Strategic Moves

Balance sheet remains solid with $500 million cash, no net debt. Free cash flow hit $120 million in 2025, funding buybacks and dividends initiation at $0.10/share quarterly. ROIC exceeds 20%, top-tier in peers.

Strategic acquisitions like Astera Labs test interfaces expand portfolio. Partnerships with NVIDIA on Blackwell testing position for next-gen AI. Management guides 10-15% revenue growth for 2026, assuming stable demand.

Outlook and Valuation Considerations

Analysts maintain Buy ratings, target $55 USD on NASDAQ, implying 30% upside. Bull case hinges on AI spend resuming; bear case sees 20% revenue dip if probe escalates. Volatility suits tactical traders.

For long-term DACH investors, FormFactor fits thematic portfolios on digital transformation. Monitor Q1 earnings on April 24 for probe updates. Sector rotation favors tools if memory recovers.

Disclaimer: This is not investment advice. Stocks are volatile financial instruments.